Name: UMIN ID:
Unique ID issued by UMIN | UMIN000015779 |
---|---|
Receipt number | R000018090 |
Scientific Title | Phase III study evaluating palbociclib (PD-0332991), a Cyclin-Dependent Kinase (CDK) 4/6 Inhibitor in patients with hormone-receptor-positive, HER2-normal primary breast cancer with high relapse risk after neoadjuvant chemotherapy "PENELOPEB" |
Date of disclosure of the study information | 2014/12/01 |
Last modified on | 2021/06/29 13:39:56 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2014/11/28 17:35:05 | ||
2 | Update | 2014/12/18 15:18:05 | Public title Acronym |
|
3 | Update | 2015/03/20 14:28:24 | Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria Target sample size |
|
4 | Update | 2015/04/24 10:19:36 | Recruitment status |
|
5 | Update | 2016/08/01 11:28:56 | UMIN ID1 |
|
6 | Update | 2016/08/01 14:48:42 | Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Name of primary person or sponsor Organization |
|
7 | Update | 2017/11/30 11:32:44 | Recruitment status |
|
8 | Update | 2018/08/17 10:24:50 | Acronym Acronym |
|
9 | Update | 2018/08/24 10:10:23 | UMIN ID1 |
|
10 | Update | 2019/03/20 13:39:24 | UMIN ID2 |
|
11 | Update | 2019/07/18 16:58:04 | Randomization unit Dynamic allocation Institution consideration |
|
12 | Update | 2019/09/05 15:39:32 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |
|
13 | Update | 2019/09/05 15:41:27 | Number of participants that the trial has enrolled |
|
14 | Update | 2019/09/05 15:46:36 | Date of IRB Last follow-up date |
|
15 | Update | 2021/06/25 16:45:58 | URL releasing protocol URL related to results and publications Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
16 | Update | 2021/06/28 08:42:01 | Recruitment status |
|
17 | Update | 2021/06/29 13:35:16 | UMIN ID2 |
|
18 | Update | 2021/06/29 13:39:56 | Last name of contact person Last name of contact person Organization Organization Division name Division name Zip code Address Address TEL Name of person sending information Name of person sending information |